Announcements Trials
Browse Landscape

Phase

Phase 2 42Phase 3 24Phase 1 13Phase 1/2 7Phase 2/3 3Phase 4 2Phase NA 1Phase EARLY_PHASE1 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 13Breast Neoplasms 9Rectal Neoplasms 3Neoplasm Metastasis 2Colonic Neoplasms 2Upper Gastrointestinal Tumours 1TTP 1Stomach Neoplasms 1Recurrence 1Patient Acceptance of Health Care 1Pancreatic Cancer Non-resectable 1Locally Advanced Colorectal Cancer 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1HER-2 Positive Gastric Cancer 1Frailty 1

Interventions

Propofol 3Oxaliplatin 3Morphine 3Fentanyl 3Sevoflurane 2Ropivacaine 2Fluorouracil 2Capecitabine 2Bupivacaine 2Bevacizumab 2Acetaminophen 2polyethylene glycol 3350 1oxycodone-acetaminophen 1gatorade 1fish oil triglycerides 1Vitamin D 1Tranexamic Acid 1Tramadol 1Tegafur 1Sodium Chloride 1Simethicone 1Saline Solution 1Rivaroxaban 1Polyethylene Glycols 1Pirinitramide 1Panitumumab 1Orphenadrine 1Neuroleptanalgesia 1Midazolam 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Colonic Neoplasms × Capecitabine × Clear all
NCT00559676 2011-05-16

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 4 Completed
200 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00216424 2007-11-12

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

James A. Haley Veterans Administration Hospital

Phase 4 Terminated
40 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡